CH CRL (R4)
0.9.0 - Draft
CH CRL (R4)
0.9.0 - Draft
This page is part of the CH CRL (R4) (v0.9.0: STU Draft) based on FHIR R4. . For a full list of available versions, see the Directory of published versions 
{
"resourceType" : "CodeSystem",
"id" : "nkrs-variables",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This code system http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-variables defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">3.6.2<a name=\"nkrs-variables-3.466.462\"> </a></td><td>Associated in situ tumour</td></tr><tr><td style=\"white-space:nowrap\">3.9.1<a name=\"nkrs-variables-3.469.461\"> </a></td><td>ICCC-3 main group</td></tr><tr><td style=\"white-space:nowrap\">3.9.2<a name=\"nkrs-variables-3.469.462\"> </a></td><td>ICCC-3 code</td></tr><tr><td style=\"white-space:nowrap\">3.9.3<a name=\"nkrs-variables-3.469.463\"> </a></td><td>ICCC-3 extended code</td></tr><tr><td style=\"white-space:nowrap\">4.19<a name=\"nkrs-variables-4.4619\"> </a></td><td>COG staging</td></tr><tr><td style=\"white-space:nowrap\">4.20<a name=\"nkrs-variables-4.4620\"> </a></td><td>COG ALL staging</td></tr><tr><td style=\"white-space:nowrap\">4.21<a name=\"nkrs-variables-4.4621\"> </a></td><td>FIGO staging</td></tr><tr><td style=\"white-space:nowrap\">4.22<a name=\"nkrs-variables-4.4622\"> </a></td><td>INRGSS staging</td></tr><tr><td style=\"white-space:nowrap\">4.23<a name=\"nkrs-variables-4.4623\"> </a></td><td>IRSS staging</td></tr><tr><td style=\"white-space:nowrap\">4.24<a name=\"nkrs-variables-4.4624\"> </a></td><td>Lugano staging</td></tr><tr><td style=\"white-space:nowrap\">4.25<a name=\"nkrs-variables-4.4625\"> </a></td><td>PRETEXT staging</td></tr><tr><td style=\"white-space:nowrap\">4.28<a name=\"nkrs-variables-4.4628\"> </a></td><td>Rhabdomyosarcoma site staging</td></tr><tr><td style=\"white-space:nowrap\">4.30<a name=\"nkrs-variables-4.4630\"> </a></td><td>DSSplus</td></tr><tr><td style=\"white-space:nowrap\">4.31<a name=\"nkrs-variables-4.4631\"> </a></td><td>SIOP staging</td></tr><tr><td style=\"white-space:nowrap\">4.32<a name=\"nkrs-variables-4.4632\"> </a></td><td>St. Jude / Murphy staging</td></tr><tr><td style=\"white-space:nowrap\">4.33.2<a name=\"nkrs-variables-4.4633.462\"> </a></td><td>Toronto Tier II (manual) staging</td></tr><tr><td style=\"white-space:nowrap\">4.34<a name=\"nkrs-variables-4.4634\"> </a></td><td>Creasman grading system</td></tr><tr><td style=\"white-space:nowrap\">4.35<a name=\"nkrs-variables-4.4635\"> </a></td><td>Elston/Ellis grading system</td></tr><tr><td style=\"white-space:nowrap\">4.36<a name=\"nkrs-variables-4.4636\"> </a></td><td>SalzerKuntschik grading system</td></tr><tr><td style=\"white-space:nowrap\">4.37<a name=\"nkrs-variables-4.4637\"> </a></td><td>Shimada grading system</td></tr><tr><td style=\"white-space:nowrap\">4.38<a name=\"nkrs-variables-4.4638\"> </a></td><td>WHO(CNS) grading system</td></tr><tr><td style=\"white-space:nowrap\">4.39<a name=\"nkrs-variables-4.4639\"> </a></td><td>Clinical tumour size</td></tr><tr><td style=\"white-space:nowrap\">4.40<a name=\"nkrs-variables-4.4640\"> </a></td><td>Pathological tumour size</td></tr><tr><td style=\"white-space:nowrap\">6.1<a name=\"nkrs-variables-6.461\"> </a></td><td>Residual invasive tumour</td></tr><tr><td style=\"white-space:nowrap\">6.2<a name=\"nkrs-variables-6.462\"> </a></td><td>Residual in-situ tumour</td></tr><tr><td style=\"white-space:nowrap\">6.3<a name=\"nkrs-variables-6.463\"> </a></td><td>Resection margin invasive tumour</td></tr><tr><td style=\"white-space:nowrap\">6.4<a name=\"nkrs-variables-6.464\"> </a></td><td>Resection margin in-situ tumour</td></tr><tr><td style=\"white-space:nowrap\">8.4<a name=\"nkrs-variables-8.464\"> </a></td><td>Morphology term before change of main diagnosis</td></tr><tr><td style=\"white-space:nowrap\">8.5<a name=\"nkrs-variables-8.465\"> </a></td><td>Morphology term after Transformation</td></tr><tr><td style=\"white-space:nowrap\">8.6<a name=\"nkrs-variables-8.466\"> </a></td><td>Topography(s) of post-diagnosis metastases</td></tr><tr><td style=\"white-space:nowrap\">10.3<a name=\"nkrs-variables-10.463\"> </a></td><td>HIV/AIDS</td></tr><tr><td style=\"white-space:nowrap\">10.9<a name=\"nkrs-variables-10.469\"> </a></td><td>Cerebrovascular Accident or Transient Ischemic Attack</td></tr><tr><td style=\"white-space:nowrap\">10.11<a name=\"nkrs-variables-10.4611\"> </a></td><td>Hemiplegia / Paraplegia</td></tr><tr><td style=\"white-space:nowrap\">10.12<a name=\"nkrs-variables-10.4612\"> </a></td><td>Connective Tissue Disease - Rheumatic disease</td></tr></table></div>"
},
"url" : "http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-variables",
"version" : "0.9.0",
"name" : "NkrsVariables",
"title" : "NKRS Variables",
"status" : "active",
"date" : "2022-02-04T14:14:21+01:00",
"publisher" : "Bundesamt für Gesundheit BAG",
"contact" : [
{
"name" : "Bundesamt für Gesundheit BAG",
"telecom" : [
{
"system" : "url",
"value" : "https://www.bag.admin.ch/"
}
]
}
],
"description" : "NKRS codes for data elements for which there is no international code (e.g. LOINC or SNOMED CT) \r\nthat accurately describes the meaning of the NKRS variable. This code system is based on \r\n\\'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)\\'\r\n([EN](https://www.nacr.ch/assets/files/uploads/a-datadictionary-basicvariables-v1.1.pdf), \r\n[DE](https://www.nkrs.ch/assets/files/uploads/a-datenstruktur-variablen-der-basisdaten-v1.1.pdf), \r\n[FR](https://www.onec.ch/assets/files/uploads/a-dict-des-donnees-variables-de-base-v1.1.pdf), \r\n[IT](https://www.snrt.ch/assets/files/uploads/a-dati-oncologici-variabili-di-base-v1.1.pdf)) \r\nand \r\n\\'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part B1, SUPPLEMENTARY VARIABLES for Adults (15.10.2019)\\'\r\n([EN](https://www.nacr.ch/assets/files/uploads/b1-datadictionary-supplementaryvariables-adults-v1.1.pdf), \r\n[DE](https://www.nkrs.ch/assets/files/uploads/variablen-zusatzdaten-kinderjugendliche-v1.1.pdf), \r\n[FR](https://www.onec.ch/assets/files/uploads/b1-dict-des-donnees-variables-suppl-adultes-v1.1.pdf), \r\n[IT](https://www.snrt.ch/assets/files/uploads/b1-variabili-supplementari-adulti-v1.1.pdf)).",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "CH"
}
]
}
],
"copyright" : "CC-BY-SA-4.0",
"caseSensitive" : true,
"content" : "complete",
"count" : 34,
"concept" : [
{
"code" : "3.6.2",
"display" : "Associated in situ tumour"
},
{
"code" : "3.9.1",
"display" : "ICCC-3 main group"
},
{
"code" : "3.9.2",
"display" : "ICCC-3 code"
},
{
"code" : "3.9.3",
"display" : "ICCC-3 extended code"
},
{
"code" : "4.19",
"display" : "COG staging"
},
{
"code" : "4.20",
"display" : "COG ALL staging"
},
{
"code" : "4.21",
"display" : "FIGO staging"
},
{
"code" : "4.22",
"display" : "INRGSS staging"
},
{
"code" : "4.23",
"display" : "IRSS staging"
},
{
"code" : "4.24",
"display" : "Lugano staging"
},
{
"code" : "4.25",
"display" : "PRETEXT staging"
},
{
"code" : "4.28",
"display" : "Rhabdomyosarcoma site staging"
},
{
"code" : "4.30",
"display" : "DSSplus"
},
{
"code" : "4.31",
"display" : "SIOP staging"
},
{
"code" : "4.32",
"display" : "St. Jude / Murphy staging"
},
{
"code" : "4.33.2",
"display" : "Toronto Tier II (manual) staging"
},
{
"code" : "4.34",
"display" : "Creasman grading system"
},
{
"code" : "4.35",
"display" : "Elston/Ellis grading system"
},
{
"code" : "4.36",
"display" : "SalzerKuntschik grading system"
},
{
"code" : "4.37",
"display" : "Shimada grading system"
},
{
"code" : "4.38",
"display" : "WHO(CNS) grading system"
},
{
"code" : "4.39",
"display" : "Clinical tumour size"
},
{
"code" : "4.40",
"display" : "Pathological tumour size"
},
{
"code" : "6.1",
"display" : "Residual invasive tumour"
},
{
"code" : "6.2",
"display" : "Residual in-situ tumour"
},
{
"code" : "6.3",
"display" : "Resection margin invasive tumour"
},
{
"code" : "6.4",
"display" : "Resection margin in-situ tumour"
},
{
"code" : "8.4",
"display" : "Morphology term before change of main diagnosis"
},
{
"code" : "8.5",
"display" : "Morphology term after Transformation"
},
{
"code" : "8.6",
"display" : "Topography(s) of post-diagnosis metastases"
},
{
"code" : "10.3",
"display" : "HIV/AIDS"
},
{
"code" : "10.9",
"display" : "Cerebrovascular Accident or Transient Ischemic Attack"
},
{
"code" : "10.11",
"display" : "Hemiplegia / Paraplegia"
},
{
"code" : "10.12",
"display" : "Connective Tissue Disease - Rheumatic disease"
}
]
}